Allergan Investors Win Cert. In Valeant Insider Trading Row
By Melissa Daniels ( March 15, 2017, 10:15 PM EDT) -- A California federal judge on Wednesday granted class certification in a stock-drop suit against Valeant Pharmaceuticals and William Ackman's Pershing Square Capital Management LP over an attempted $55 billion takeover of Allergan Inc., saying Allergan investors who sold their stock have alleged common losses that bind them together....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.